Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
01/2009
01/15/2009US20090017489 Methods For Modulating The Development Of Dopamine Neuron By The Dopamine D2 Receptor And Compositions Thereof
01/15/2009CA2690719A1 Treatment of neuropathic pain
01/14/2009EP2013835A2 Preparation of chiral amides and amines
01/14/2009EP1477472B1 Substituted phenylalkanoic acid derivative and use thereof
01/14/2009EP1345899B1 N-substituted amides as NK1 receptor antagonists
01/14/2009CN101346410A Dihydroxy aromatic compounds, methods for preparation polymers made therefrom, and method of polymer preparation
01/14/2009CN101343241A Purification process for Oseltamivir Phosphate
01/14/2009CN100450994C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
01/13/2009US7476764 e.g. N1-((2S,3R)-4-(3-methoxybenzylamino)-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl)-5-acetyl-N3,N3-dipropylisophthalamide TFA salt;amyloid precursor protein (APP) and production of A beta -peptide inhibitor; neurodegenerative diseases; Alzheimer's disease, Down's Syndrome
01/13/2009US7476763 e.g. 5-oxo-5-phenyl-valeric acid 4-dimethylamino-4-phenyl-cyclohexyl)-amide; opioid receptor modulator; noradrenaline and serotonin reuptake inhibitor; antidepressant, anxiolytic, analgesic agent; neurodegenerative diseases; linking a cyclohexane-1,4-diamine with a carboxylic acid
01/13/2009US7476759 Matrix metalloproteinase inhibitors
01/13/2009US7476758 excellent inhibitory activity against alpha 4 integrin-mediated cell adhesion; allergic bronchitis, inflammatory bowel disease, rheumatoid arthritis, experimental autoimmune encephalomyelitis
01/13/2009US7476755 e.g. 5-(3-{(1S,2S)-2-[4-(1-Hydroxy-hexyl)-phenyl]-3-oxo-cyclopentyl}-propyl)-thiophene-2-carboxylic acid; prostaglandin receptor ligand; antiinflammatory agent; glaucoma or ocular hypertension
01/13/2009US7476754 Biphenyl derived thiamides as calpain inhibitors
01/13/2009US7476751 Process for the synthesis of (7-methoxy-1-naphthyl)acetonitrile and its application in the synthesis of agomelatine
01/13/2009US7476399 Amide compounds such as (R)-methyl 2-(3-chloro-4-methoxybenzamido)-4-methylpentanoate and urea compounds such as 1-(2-chlorophenyl)-3-(heptan-4-yl)urea for modulating taste of food or drug products
01/13/2009CA2459175C An improved process for the synthesis of (±)2-amino-n-(2,(2,5-dimethoxyphenyl)-2-hydroxyethyl) acetamide monohydrochloride
01/08/2009WO2009005801A1 Process and intermediates for the synthesis of 1,2-substituted 3,4-dioxo-1-cyclobutene compounds
01/08/2009WO2009005076A1 Amide compound
01/08/2009WO2009005005A1 Composite material and method for production thereof
01/08/2009WO2009004643A2 An improved process for preparation of (s)-pregabalin and intermediates thereof
01/08/2009WO2009003589A1 A process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylates
01/08/2009US20090012153 Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors
01/08/2009US20090012010 Amino acid derivatives as calcium channel blockers
01/08/2009US20090010853 Contrast agents
01/08/2009DE102007030695A1 Co-crystal, useful e.g. to prepare a pharmaceutical formulation for the treatment of psychosis, neurological disorder and struma lymphomatosa, comprises an amino compound and urea as further component
01/08/2009CA2692269A1 Process and intermediates for the synthesis of 1,2-substituted 3,4-dioxo-1-cyclobutene compounds
01/08/2009CA2692265A1 Amide compounds
01/08/2009CA2692222A1 A process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylates
01/07/2009EP1483273B1 Ligands for asymmetric reactions
01/07/2009CN101340906A Therapeutic agent or therapeutic method for ischemic stroke
01/07/2009CN101338000A Co-producing process of polyvinyl alcohol and N,N-dimethylacetamide
01/07/2009CN101337905A Process for extracting alkaloid from pepper monomer
01/07/2009CN101337904A Synthesis of DMF and device
01/07/2009CN101337897A Process for preparing ambroxol, analogue thereof or salts thereof
01/07/2009CN100448968C Detergent compositions and processes for the production thereof
01/07/2009CN100448844C Inhibitors of histone deacetylase
01/06/2009CA2371818C Salicylamide-lanthanide complexes for use as luminescent markers
01/06/2009CA2348084C Crystallisation using supercritical or subcritical fluids
01/06/2009CA2169219C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and pharmaceutical preparations containing them
01/01/2009US20090005453 Crystalline forms of tigecycline and processes for preparation thereof
01/01/2009US20090005434 Novel Salicylic Anilides
01/01/2009US20090005433 Fluorinated Compounds
01/01/2009US20090005323 Cathepsin K Inhibitors and Obesity
12/2008
12/31/2008WO2009000397A1 Process for preparing benzyl pentahydroxyhexylcarbamoylundecanoate
12/31/2008EP2008994A1 New crystalline form IV of agomelatine, method of preparing same and pharmaceutical compositions containing same
12/31/2008EP2008993A1 New crystalline form III of agomelatine, method of preparing same and pharmaceutical compositions containing same
12/31/2008EP1558230B1 Spirocyclopropyl amides and acids and their therapeutic applications
12/31/2008EP1465835B1 Preparation of non-hazardous brominating reagents
12/31/2008EP1276741B1 Phenyl substituted 4-hydroxy tetrahydropyridone and its use as pesticide and herbicide
12/31/2008CN101336232A 3'-alkoxy-spirocyclopentyl-substituted tetramic and tetronic acids
12/31/2008CN101336229A 改性的拟赖氨酸化合物 Proposed modification of lysine compound
12/31/2008CN101336228A Process for the manufacture of iohexol
12/31/2008CN101336227A Nuclear receptor binding agents
12/31/2008CN101333178A Substituted benzene monsulfonic acid (2-methoxyl-4-aminomethyl) phenol ester and method for synthesizing same
12/31/2008CN101333172A Method for making 2,2,3,3,-tetramethyl cyclopropanecarboxylicamide and amines
12/31/2008CA2691065A1 Process for preparing benzyl pentahydroxyhexylcarbamoylundecanoate
12/30/2008US7470817 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried
12/30/2008US7470810 Such as 1-dodecane-thiotrifluoroacetate; alkyl/arylthiol is treated with trifluoroacetic anhydride in presence of pyridine, solvent (dichloromethane), and dimethylaminopyridine (DMAP) as catalyst; for protection of amino acids
12/30/2008US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
12/30/2008US7470806 Process for the synthesis of (7-methoxy-1-naphthyl) acetonitrile and its application in the synthesis of agomelatine
12/30/2008CA2391293C .beta.2-adrenergic receptor agonists
12/25/2008US20080319222 Crystal forms of N- (trans-4-isopropylctyclohexylcarbonyl) -D-phenylalanine
12/25/2008US20080319082 Biphenyl and Naphthyl-Phenyl Hydroxamic Acid Derivatives
12/25/2008US20080319080 Amide Compounds and Their Use
12/25/2008US20080319075 Polymorphic forms of nateglinide
12/25/2008US20080319055 Cooling Compounds
12/25/2008US20080318779 Fungicidal Composition Containing Acid Amide Derivative
12/25/2008US20080318255 Fluorescent Labeled Sphingosines
12/25/2008US20080317839 Amino acid lipids and uses thereof
12/25/2008US20080317729 Ammonium Salts and Ammonium Salt/Mineral Salt Clathrate Compounds for Use as Vehicle and Effective Form for Pharmaco-Medical Applications and for Use as Phase Transfer Agents for Chemical Applications
12/25/2008US20080315147 Perfluoroalkyl substituted acrylate monomers and polymers thereof
12/24/2008WO2008157777A1 Phenyl ester side chains to increase polymer resorptivity
12/24/2008WO2007115185A3 Preparation of chiral amides and amines
12/24/2008EP2006390A1 Process for production of acrylamide
12/24/2008EP2004650A2 Process for the preparation of zaleplon and an intermediate thereof
12/24/2008EP2004593A1 Improved crystalline material
12/24/2008EP1095006B1 Derivatives of 1-oxyl-4-hydroxy-2,2,6,6-tetramethylpiperidine as polymerization inhibitors for (meth) acrylate monomers
12/24/2008CN101328134A Method for splitting 3-acetamido methyl butyrate antipode
12/24/2008CN101328133A Synthetic method of m-amino acetanilide
12/24/2008CN101328132A Continuous production method of N,N-dimethylacetamide
12/24/2008CN101328117A 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
12/24/2008CN101328110A Preparation of butoconazole nitrate intermediate
12/23/2008US7468462 Modulate activity of Nuclear Retinoid receptors; regulating cell differentiation and cell cycle processes and cellular signaling processes regulated by thyroid hormone, vitamin D, all-trans retinoic acid; 2-[6-(3-Adamantan-1-yl-4-methoxyphenyl)-naphthalen-2-yl]-3-hydroxy-cyclopent-2-enone
12/23/2008US7468440 Malonamides and malonamide derivatives as modulators of chemokine receptor activity
12/23/2008CA2492096C Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives serving as pesticides
12/23/2008CA2386627C Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
12/18/2008WO2008154372A1 Mutual prodrugs and methods to treat cancer
12/18/2008WO2008152334A2 Novel derivatives of 3-phenyl acrylic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions
12/18/2008WO2008152333A2 Novel derivatives of 3-phenyl propanoic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions
12/18/2008WO2008109991A8 Inhibitors of carnitine palmitoyltransferase and treating cancer
12/18/2008WO2008101975A3 New n-(3-phenylpropyl)benzamide derivatives
12/18/2008US20080312286 Indanone Potentiators of Metabotropic Glutamate Receptors
12/18/2008US20080312237 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
12/18/2008US20080312186 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions
12/18/2008CA2690265A1 Mutual prodrugs and methods to treat cancer
12/18/2008CA2688241A1 Novel derivatives of 3-phenyl acrylic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions
12/18/2008CA2688239A1 Novel derivatives of 3-phenyl propanoic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions
12/17/2008EP2003113A1 Process for production of carboxylic acid chloride compound
12/17/2008EP2001831A2 Compounds which inhibit the glycine transporter and uses thereof
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 289